Lasonolide A, a potent and reversible inducer of chromosome condensation

Reference

• Horton PA, Koehn FE, Longley RE, Mcconnell OJ. Lasonolide-a, a New Cytotoxic Macrolide from the Marine Sponge Forcepia Sp. J Am Chem Soc 1994; 116:6015 - 6; http://dx.doi.org/10.1021/ja00092a081
   Web of Science ®Google Scholar
• Dalgard JE, Rychnovsky SD. Enantioselective synthesis of the C18-C25 segment of lasonolide A by an oxonia-cope prins cascade. Org Lett 2005; 7:1589 - 91; http://dx.doi.org/10.1021/ol050270s; PMID: 15816759
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Yakushiji F, Kondo S, Wu X, Shindo M, Shishido K. Total synthesis of (+)-lasonolide A. Org Lett 2006; 8:475 - 8; http://dx.doi.org/10.1021/ol0527678; PMID: 16435863
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Gong G. Enantioselective total synthesis of macrolide antitumor agent (-)-lasonolide A. Org Lett 2007; 9:1437 - 40; http://dx.doi.org/10.1021/ol0701013; PMID: 17367152
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Ren GB. Stereoselective synthesis of both tetrahydropyran rings of the antitumor macrolide, (-)-lasonolide A. J Org Chem 2012; 77:2559 - 65; http://dx.doi.org/10.1021/jo202631e; PMID: 22324913
   PubMed Web of Science ®Google Scholar
• Isbrucker RA, Guzmán EA, Pitts TP, Wright AE. Early effects of lasonolide a on pancreatic cancer cells. J Pharmacol Exp Ther 2009; 331:733 - 9; http://dx.doi.org/10.1124/jpet.109.155531; PMID: 19692635
   PubMed Web of Science ®Google Scholar
• Cuvier O, Hirano T. A role of topoisomerase II in linking DNA replication to chromosome condensation. J Cell Biol 2003; 160:645 - 55; http://dx.doi.org/10.1083/jcb.200209023; PMID: 12604590
   PubMed Web of Science ®Google Scholar
• Gonzalez RE, Lim CU, Cole K, Bianchini CH, Schools GP, Davis BE, et al. Effects of conditional depletion of topoisomerase II on cell cycle progression in mammalian cells. Cell Cycle 2011; 10:3505 - 14; http://dx.doi.org/10.4161/cc.10.20.17778; PMID: 22067657
   PubMed Web of Science ®Google Scholar
• Uemura T, Ohkura H, Adachi Y, Morino K, Shiozaki K, Yanagida M. DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe. Cell 1987; 50:917 - 25; http://dx.doi.org/10.1016/0092-8674(87)90518-6; PMID: 3040264
   PubMed Web of Science ®Google Scholar
• Lipp JJ, Hirota T, Poser I, Peters JM. Aurora B controls the association of condensin I but not condensin II with mitotic chromosomes. J Cell Sci 2007; 120:1245 - 55; http://dx.doi.org/10.1242/jcs.03425; PMID: 17356064
   PubMed Web of Science ®Google Scholar
• Hagstrom KA, Holmes VF, Cozzarelli NR, Meyer BJ. C. elegans condensin promotes mitotic chromosome architecture, centromere organization, and sister chromatid segregation during mitosis and meiosis. Genes Dev 2002; 16:729 - 42; http://dx.doi.org/10.1101/gad.968302; PMID: 11914278
   PubMed Web of Science ®Google Scholar
• Giet R, Glover DM. Drosophila aurora B kinase is required for histone H3 phosphorylation and condensin recruitment during chromosome condensation and to organize the central spindle during cytokinesis. J Cell Biol 2001; 152:669 - 82; http://dx.doi.org/10.1083/jcb.152.4.669; PMID: 11266459
   PubMed Web of Science ®Google Scholar
• Van Hooser A, Goodrich DW, Allis CD, Brinkley BR, Mancini MA. Histone H3 phosphorylation is required for the initiation, but not maintenance, of mammalian chromosome condensation. J Cell Sci 1998; 111:3497 - 506; PMID: 9811564
   PubMed Web of Science ®Google Scholar
• Guo XW, Th’ng JP, Swank RA, Anderson HJ, Tudan C, Bradbury EM, et al. Chromosome condensation induced by fostriecin does not require p34cdc2 kinase activity and histone H1 hyperphosphorylation, but is associated with enhanced histone H2A and H3 phosphorylation. EMBO J 1995; 14:976 - 85; PMID: 7889943
   PubMed Web of Science ®Google Scholar
• Ghosh S, Schroeter D, Paweletz N. Okadaic acid overrides the S-phase check point and accelerates progression of G2-phase to induce premature mitosis in HeLa cells. Exp Cell Res 1996; 227:165 - 9; http://dx.doi.org/10.1006/excr.1996.0262; PMID: 8806464
   PubMed Web of Science ®Google Scholar
• Tosuji H, Mabuchi I, Fusetani N, Nakazawa T. Calyculin A induces contractile ring-like apparatus formation and condensation of chromosomes in unfertilized sea urchin eggs. Proc Natl Acad Sci U S A 1992; 89:10613 - 7; http://dx.doi.org/10.1073/pnas.89.22.10613; PMID: 1438256
   PubMed Web of Science ®Google Scholar
• Miura T, Blakely WF. Optimization of calyculin A-induced premature chromosome condensation assay for chromosome aberration studies. Cytometry A 2011; 79:1016 - 22; http://dx.doi.org/10.1002/cyto.a.21154; PMID: 22052612
   PubMed Web of Science ®Google Scholar
• Prasanna PG, Blakely WF. Premature chromosome condensation in human resting peripheral blood lymphocytes for chromosome aberration analysis using specific whole-chromosome DNA hybridization probes. Methods Mol Biol 2005; 291:49 - 57; PMID: 15502211
   PubMedGoogle Scholar
• Moreno S, Hayles J, Nurse P. Regulation of p34cdc2 protein kinase during mitosis. Cell 1989; 58:361 - 72; http://dx.doi.org/10.1016/0092-8674(89)90850-7; PMID: 2665944
   PubMed Web of Science ®Google Scholar
• Gotoh E, Durante M. Chromosome condensation outside of mitosis: mechanisms and new tools. J Cell Physiol 2006; 209:297 - 304; http://dx.doi.org/10.1002/jcp.20720; PMID: 16810672
   PubMed Web of Science ®Google Scholar
• Yamashita K, Yasuda H, Pines J, Yasumoto K, Nishitani H, Ohtsubo M, et al. Okadaic acid, a potent inhibitor of type 1 and type 2A protein phosphatases, activates cdc2/H1 kinase and transiently induces a premature mitosis-like state in BHK21 cells. EMBO J 1990; 9:4331 - 8; PMID: 2176149
   PubMed Web of Science ®Google Scholar
• Moreno S, Hayles J, Nurse P. Regulation of the cell cycle timing of mitosis. J Cell Sci Suppl 1989; 12:1 - 8; PMID: 2699733
   PubMedGoogle Scholar
• Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 1997; 243:527 - 36; http://dx.doi.org/10.1111/j.1432-1033.1997.t01-2-00527.x; PMID: 9030781
   PubMedGoogle Scholar
• Senderowicz AM. Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials. Invest New Drugs 1999; 17:313 - 20; http://dx.doi.org/10.1023/A:1006353008903; PMID: 10665481
   PubMed Web of Science ®Google Scholar
• Halmer L, Gruss C. Effects of cell cycle dependent histone H1 phosphorylation on chromatin structure and chromatin replication. Nucleic Acids Res 1996; 24:1420 - 7; http://dx.doi.org/10.1093/nar/24.8.1420; PMID: 8628673
   PubMed Web of Science ®Google Scholar
• de la Barre AE, Angelov D, Molla A, Dimitrov S. The N-terminus of histone H2B, but not that of histone H3 or its phosphorylation, is essential for chromosome condensation. EMBO J 2001; 20:6383 - 93; http://dx.doi.org/10.1093/emboj/20.22.6383; PMID: 11707409
   PubMed Web of Science ®Google Scholar
• Marks PA, Xu WS. Histone deacetylase inhibitors: Potential in cancer therapy. J Cell Biochem 2009; 107:600 - 8; http://dx.doi.org/10.1002/jcb.22185; PMID: 19459166
   PubMed Web of Science ®Google Scholar
• Escargueil AE, Larsen AK. Mitosis-specific MPM-2 phosphorylation of DNA topoisomerase IIalpha is regulated directly by protein phosphatase 2A. Biochem J 2007; 403:235 - 42; http://dx.doi.org/10.1042/BJ20061460; PMID: 17212588
   PubMed Web of Science ®Google Scholar
• Taagepera S, Dent P, Her JH, Sturgill TW, Gorbsky GJ. The MPM-2 antibody inhibits mitogen-activated protein kinase activity by binding to an epitope containing phosphothreonine-183. Mol Biol Cell 1994; 5:1243 - 51; PMID: 7532473
   PubMed Web of Science ®Google Scholar
• Pommier Y, Leo E, Zhang H, Marchand C. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 2010; 17:421 - 33; http://dx.doi.org/10.1016/j.chembiol.2010.04.012; PMID: 20534341
   PubMed Web of Science ®Google Scholar
• Balakrishnan S, Shirsath K, Bhat N, Anjaria K. Biodosimetry for high dose accidental exposures by drug induced premature chromosome condensation (PCC) assay. Mutat Res 2010; 699:11 - 6; http://dx.doi.org/10.1016/j.mrgentox.2010.03.008; PMID: 20338261
   PubMed Web of Science ®Google Scholar
• Kanda R, Eguchi-Kasai K, Hayata I. Phosphatase inhibitors and premature chromosome condensation in human peripheral lymphocytes at different cell-cycle phases. Somat Cell Mol Genet 1999; 25:1 - 8; http://dx.doi.org/10.1023/B:SCAM.0000007135.12486.e3; PMID: 10925699
   PubMedGoogle Scholar
• Prasanna PG, Blakely WF. Premature chromosome condensation in human resting peripheral blood lymphocytes for chromosome aberration analysis using specific whole-chromosome DNA hybridization probes. Methods Mol Biol 2005; 291:49 - 57; PMID: 15502211
   PubMedGoogle Scholar
• Xu D, Bai J, Duan Q, Costa M, Dai W. Covalent modifications of histones during mitosis and meiosis. Cell Cycle 2009; 8:3688 - 94; http://dx.doi.org/10.4161/cc.8.22.9908; PMID: 19855177
   PubMed Web of Science ®Google Scholar
• Wang F, Dai J, Daum JR, Niedzialkowska E, Banerjee B, Stukenberg PT, et al. Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis. Science 2010; 330:231 - 5; http://dx.doi.org/10.1126/science.1189435; PMID: 20705812
   PubMed Web of Science ®Google Scholar
• Polioudaki H, Markaki Y, Kourmouli N, Dialynas G, Theodoropoulos PA, Singh PB, et al. Mitotic phosphorylation of histone H3 at threonine 3. FEBS Lett 2004; 560:39 - 44; http://dx.doi.org/10.1016/S0014-5793(04)00060-2; PMID: 14987995
   PubMed Web of Science ®Google Scholar
• Baek SH. When signaling kinases meet histones and histone modifiers in the nucleus. Mol Cell 2011; 42:274 - 84; http://dx.doi.org/10.1016/j.molcel.2011.03.022; PMID: 21549306
   PubMed Web of Science ®Google Scholar
• Wang F, Ulyanova NP, van der Waal MS, Patnaik D, Lens SM, Higgins JM. A positive feedback loop involving Haspin and Aurora B promotes CPC accumulation at centromeres in mitosis. Curr Biol 2011; 21:1061 - 9; http://dx.doi.org/10.1016/j.cub.2011.05.016; PMID: 21658950
   PubMed Web of Science ®Google Scholar
• Edmondson DG, Davie JK, Zhou J, Mirnikjoo B, Tatchell K, Dent SY. Site-specific loss of acetylation upon phosphorylation of histone H3. J Biol Chem 2002; 277:29496 - 502; http://dx.doi.org/10.1074/jbc.M200651200; PMID: 12039950
   PubMed Web of Science ®Google Scholar
• Marchion DC, Bicaku E, Daud AI, Richon V, Sullivan DM, Munster PN. Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid. J Cell Biochem 2004; 92:223 - 37; http://dx.doi.org/10.1002/jcb.20045; PMID: 15108350
   PubMed Web of Science ®Google Scholar
• Nitiss JL. DNA topoisomerase II and its growing repertoire of biological functions. Nat Rev Cancer 2009; 9:327 - 37; http://dx.doi.org/10.1038/nrc2608; PMID: 19377505
   PubMed Web of Science ®Google Scholar
• Morrison C, Henzing AJ, Jensen ON, Osheroff N, Dodson H, Kandels-Lewis SE, et al. Proteomic analysis of human metaphase chromosomes reveals topoisomerase II alpha as an Aurora B substrate. Nucleic Acids Res 2002; 30:5318 - 27; http://dx.doi.org/10.1093/nar/gkf665; PMID: 12466558
   PubMed Web of Science ®Google Scholar
• Coelho PA, Queiroz-Machado J, Carmo AM, Moutinho-Pereira S, Maiato H, Sunkel CE. Dual role of topoisomerase II in centromere resolution and aurora B activity. PLoS Biol 2008; 6:e207; http://dx.doi.org/10.1371/journal.pbio.0060207; PMID: 18752348
   PubMed Web of Science ®Google Scholar
• Pommier Y, Marchand C. Interfacial inhibitors: targeting macromolecular complexes. Nat Rev Drug Discov 2012; 11:25 - 36; http://dx.doi.org/10.1038/nrd3665; PMID: 22173432
   PubMed Web of Science ®Google Scholar
• Bollen M, Gerlich DW, Lesage B. Mitotic phosphatases: from entry guards to exit guides. Trends Cell Biol 2009; 19:531 - 41; http://dx.doi.org/10.1016/j.tcb.2009.06.005; PMID: 19734049
   PubMed Web of Science ®Google Scholar
• Aceto N, Bentires-Alj M. Targeting protein-tyrosine phosphatases in breast cancer. Oncotarget 2012; 3:514 - 5; PMID: 22626783
   PubMed Web of Science ®Google Scholar
• Labbé DP, Hardy S, Tremblay ML. Protein tyrosine phosphatases in cancer: friends and foes!. Prog Mol Biol Transl Sci 2012; 106:253 - 306; http://dx.doi.org/10.1016/B978-0-12-396456-4.00009-2; PMID: 22340721
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Gong G. Total synthesis of potent antitumor agent (-)-lasonolide A: a cycloaddition-based strategy. Chem Asian J 2008; 3:1811 - 23; http://dx.doi.org/10.1002/asia.200800164; PMID: 18712746
   PubMed Web of Science ®Google Scholar
• Zhang YW, Regairaz M, Seiler JA, Agama KK, Doroshow JH, Pommier Y. Poly(ADP-ribose) polymerase and XPF-ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells. Nucleic Acids Res 2011; 39:3607 - 20; http://dx.doi.org/10.1093/nar/gkq1304; PMID: 21227924
   PubMed Web of Science ®Google Scholar